Göm menyn

Publications for Linda Åkerman


Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 18 times*

Journal Articles

Linda Åkerman, Rosaura Casas, Johnny Ludvigsson, Beatriz Tavira Iglesias and Camilla Skoglund
  Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes
  PLoS ONE, 2018, 13(1), .
   Fulltext  PDF  

Linda Åkerman, Johnny Ludvigsson, Ulrica Swartling and Rosaura Casas
  Characteristics of the pre-diabetic period in children with high risk of type 1 diabetes recruited from the general Swedish populationThe ABIS study
  Diabetes/Metabolism Research Reviews, 2017, 33(6), .
 Web of Science® Times Cited: 1

Beatriz Tavira Iglesias, Mikael Chéramy, Stina Axelsson Chéramy, Linda Åkerman, Johnny Ludvigsson and Rosaura Casas
  Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD(65)-induced immune response
  Diabetologia, 2017, 60(7), 1276-1283.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Mikael Pihl, Hugo Barcenilla, Stina Axelsson Chéramy, Mikael Chéramy, Linda Åkerman, Ingela Johansson, Johnny Ludvigsson and Rosaura Casas
  GAD-specific T cells are induced by GAD-alum treatment in Type-1 diabetes patients
  Clinical Immunology, 2017, 176, 114-121.
 Web of Science® Times Cited: 1

Karina Huus, Linda Åkerman, Anders Raustorp and Johnny Ludvigsson
  Physical Activity, Blood Glucose and C-Peptide in Healthy School-Children, a Longitudinal Study
  PLoS ONE, 2016, 11(6), e0156401.
   Fulltext  PDF  

Johnny Ludvigsson, Mikael Chéramy, Stina Axelsson, Mikael Pihl, Linda Åkerman and Rosaura Casas
  GAD-treatment of children and adolescents with recent-onset Type 1 diabetes preserves residual insulin secretion after 30 months
  Diabetes/Metabolism Research Reviews, 2014, 30(5), 405-414.
 Web of Science® Times Cited: 12

Stina Axelsson, Mikael Cheramy, Linda Åkerman, Mikael Pihl, Johnny Ludvigsson and Rosaura Casas
  Cellular and Humoral Immune responses in Type 1 Diabetic patients participating in a Phase III GAD-alum Intervention Trial
  Diabetes Care, 2013, 36(11), 3418-3424.
   Fulltext  PDF  
 Web of Science® Times Cited: 12

Linda Åkerman, Johnny Ludvigsson and Rosaura Casas
  Low C-peptide levels and decreased expression of TNF and CD45 in children with high risk of type 1 diabetes
  Clinical Immunology, 2013, 148(1), .
 Web of Science® Times Cited: 4

Mikael Pihl, Linda Åkerman, Stina Axelsson, Mikael Chéramy, Maria Hjorth, R. Mallone, Johnny Ludvigsson and Rosaura Casas
  Regulatory T cell phenotype and function 4 years after GAD–alum treatment in children with type 1 diabetes
  Clinical and Experimental Immunology, 2013, 172(3), 394-402.
   Fulltext  PDF  
 Web of Science® Times Cited: 8

Stina Axelsson, Mikael Chéramy, Maria Hjorth, Mikael Pihl, Linda Åkerman, Emanuela Martinuzzi, Roberto Mallone, Johnny Ludvigsson and Rosaura Casas
  Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes
  PLoS ONE, 2011, 6(12), .
   Fulltext  PDF  
 Web of Science® Times Cited: 25

Stina Axelsson, Maria Hjorth, Linda Åkerman, Johnny Ludvigsson and Rosaura Casas
  Early induction of GAD(65)-reactive Th2 response in type 1 diabetic children treated with alum-formulated GAD(65)
  Diabetes/Metabolism Research Reviews, 2010, 26(7), 559-568.
 Web of Science® Times Cited: 19

Ph.D. Theses

Linda Åkerman
  Aspects of the Pre-Diabetic Period in Type 1 Diabetes
  2016.


  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.

 



Responsible for this page: Peter Berkesand
Last updated: 2017-02-21